Nu Skin Enterprises Inc.
NUS | NYSE
$4.68
+$0.10 (+2.18%)
At close: Sep 21, 2026, 4:00 PM ET
$4.67
-$0.01 (-0.21%)
After-hours:
Sep 21, 2026, 7:13 PM ET
Company Profile
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
Key Executives
| Name | Position |
|---|---|
| Ryan S. Napierski | President, Chief Executive Officer & Director |
| Chayce David Clark | Executive VP, COO & Chief Legal Officer |
| Chelsea Lantz | Chief Financial Officer |
| Joe Sueper | Senior Vice President & Chief Technology Officer |
| Blake Roney | Founder |
| Hunt | VP of Treasurer, Investor Relations & Admin Services |
| Joseph Y. Chang | Executive VP, Chief Scientific Officer & Chair of Scientific Advisory Board |
| Justin Keisel | Executive VP & President of Global Sales (Leave of Absence) |
| Marion Shumway | Senior Vice President of Human Resources |
| Mikael Linder | President of Europe, Middle East & Africa Region |
| Pakapun Leevutinun | President of Southeast Asia & Pacific |
| Sandra N. Tillotson | Founder |
| Steven J. Lund | Co-Founder & Executive Chairman of the Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 21, 2026 | 8-K | Current Report |
| Aug 10, 2026 | 10-Q | Quarterly Report |
| Aug 10, 2026 | 8-K | Current Report |
| Jun 11, 2026 | 4 | Filing |
| Jun 01, 2026 | S-8 | Filing |
| May 29, 2026 | 8-K | Current Report |
| May 21, 2026 | SD | Filing |
| May 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| May 12, 2026 | 4 | Filing |
| May 08, 2026 | 8-K | Current Report |
Nu Skin Enterprises Inc.
| Country | United States |
| IPO Date | Nov 21, 1996 |
| Industry | Household & Personal Products |
| Sector | Consumer Defensive |
| Employees | 2,800 |
| CEO | Ryan S. Napierski |
Contact Details
75 West Center Street Provo,
Utah 84601 United States
Stock Details
| Ticker Symbol | NUS |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001021561 |
| CUSIP Number | 67018T105 |
| ISIN Number | US67018T1051 |
| SIC Code | 5122 |
Add to Watchlist
Select watchlists to add or remove NUS